Keyphrases
Antibody Clones
11%
B7 Family
100%
B7/CD28 Family
11%
Cancer Immunotherapy
22%
Clinical Outcomes
11%
Clinical Significance
11%
Cytotoxic T-lymphocyte antigen-4 (CTLA-4)
11%
Distinct Subtypes
11%
EGFR mutation
33%
Expression Profile
11%
Family Members
11%
Healthy Lung
11%
HHLA2
100%
Hispanic
11%
Histology
11%
Human Lung Cancer
100%
Immune Checkpoint
100%
Large Cell
11%
Limited Information
11%
Lung Adenocarcinoma
33%
Lung Cancer
11%
Lung Tissue
11%
Multivariate Analysis
11%
Mutational Status
100%
Non-Hispanic White
11%
Non-small Cell Lung Cancer (NSCLC)
66%
Programmed Death-ligand 1 (PD-L1)
11%
Specific Antibodies
11%
Squamous Cell
11%
T Cell Activation
11%
Tissue Microarray
11%
Treatment Paradigms
11%
Tumor
22%
Tumor Immune Suppression
11%
Tumor Tissue
11%
Tumor-infiltrating Lymphocytes
22%
Validation Cohort
22%
Medicine and Dentistry
Cancer Immunotherapy
33%
Cell Function
16%
Clinical Significance
16%
CTLA-4
16%
Epidermal Growth Factor Receptor
100%
Immunosuppressive Treatment
16%
Immunotherapy
16%
Large Cell
16%
Lung
16%
Lung Adenocarcinoma
50%
Lung Cancer
100%
Multivariate Analysis
16%
Neoplasm
50%
Non Small Cell Lung Cancer
100%
Programmed Death-Ligand 1
16%
T Cell
16%
Tissue Microarray
16%
Tumor
16%
Tumor Infiltrating Lymphocyte
33%
Pharmacology, Toxicology and Pharmaceutical Science
Cytotoxic T Lymphocyte Antigen 4
16%
Epidermal Growth Factor Receptor
100%
Immunotherapy
50%
Lung Adenocarcinoma
50%
Lung Cancer
100%
Malignant Neoplasm
16%
Neoplasm
83%
Non Small Cell Lung Cancer
100%
Biochemistry, Genetics and Molecular Biology
Cancer Immunotherapy
40%
CD28
20%
Cell Function
20%
CTLA-4
20%
Epidermal Growth Factor Receptor
100%
Immune Checkpoints
100%
Multivariate Analysis
20%
PD-L1
20%
T Cell
20%
Tissue Microarray
20%
Tumor-Infiltrating Lymphocytes
40%